Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease. Its products include SYMJEPI epinephrine injectable pre-filled single dose syringe products for use in the emergency treatment of acute allergic reactions comprising anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company was founded in 2006 and is headquartered in San Diego, California.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2023-08-21 |
2023-06 |
0 |
N/A |
N/A |
N/A |
2023-05-15 |
2023-03 |
0 |
N/A |
N/A |
N/A |
2023-03-16 |
2022-12 |
0 |
N/A |
N/A |
N/A |
2022-11-14 |
2022-09 |
0 |
N/A |
N/A |
N/A |
2022-08-10 |
2022-06 |
-2.8 |
N/A |
N/A |
N/A |
2022-05-16 |
2022-03 |
-2.1 |
N/A |
N/A |
N/A |
Date |
Firm |
Action |
From |
To |
2020-05-13 |
Maxim Group |
Upgrade |
Hold |
Buy |
2019-11-26 |
Raymond James |
Downgrade |
Outperform |
Market Perform |
2019-11-25 |
Maxim Group |
Downgrade |
Buy |
Hold |
2019-07-23 |
B. Riley FBR |
Upgrade |
Sell |
Neutral |
2019-07-16 |
B. Riley |
Downgrade |
Neutral |
Sell |
2018-11-12 |
B. Riley FBR |
Downgrade |
Buy |
Neutral |
Date |
Name |
Relation |
Quantity |
Description |
2022-03-17 |
BENEDICTO DAVID C. |
Chief Financial Officer |
39.88K |
Sale |
2022-05-24 |
CARLO DENNIS J |
Former |
692.46K |
Conversion of Exercise of derivative security |
2020-11-17 |
DANIELS KAREN K |
Officer |
149.24K |
Sale |
2023-05-24 |
DESAI MEERA J. |
Director |
3.14K |
Stock Award(Grant) |
2021-02-18 |
HOPKINS ROBERT O |
Chief Financial Officer |
277.07K |
Conversion of Exercise of derivative security |
2022-03-17 |
MARGUGLIO DAVID J |
Officer and Director |
239.79K |
Sale |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-03-30 |
Armistice Capital, LLC |
207.15K |
484.72K |
0.12% |
2023-03-30 |
Vanguard Group, Inc. (The) |
92.63K |
216.75K |
0.05% |
2023-03-30 |
Blackrock Inc. |
39.53K |
92.50K |
0.02% |
2023-03-30 |
Geode Capital Management, LLC |
18.95K |
44.35K |
0.01% |
2023-03-30 |
State Street Corporation |
6.79K |
15.89K |
0.00% |
2023-03-30 |
Citadel Advisors Llc |
4.67K |
10.94K |
0.00% |
Report Date |
Organization |
Position |
Value |
Percentage |
2022-12-30 |
Vanguard Total Stock Market Index Fund |
4.10M |
9.58M |
2.73% |
2022-12-30 |
Vanguard Extended Market Index Fund |
2.11M |
4.93M |
1.40% |
2023-02-27 |
Fidelity Extended Market Index Fund |
783.33K |
1.83M |
0.52% |
2023-02-27 |
Fidelity Total Market Index Fund |
200.21K |
468.48K |
0.13% |
2023-02-27 |
Fidelity Series Total Market Index Fund |
167.25K |
391.37K |
0.11% |
2022-12-30 |
Vanguard Institutional Index-Inst Total Stock Market Ind |
114.37K |
267.62K |
0.08% |
Split |
Date |
1 : 70 |
2023-05-22 |
0.05882 : 1 |
2013-12-13 |
0.10072 : 1 |
2009-04-22 |